Value share of pharmaceutical subsectors worldwide 2003-2021

In 2021, Big Pharma accounted for 48 percent of the pharmaceutical market value worldwide, a significant decrease from 77 percent in 2003. This statistic illustrates the share of the pharmaceutical subsectors worldwide comparing the situation in 2003 and 2021.

Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*

Characteristic	Big Pharma	Branded Pharma	China Pharma	Branded Generics	Biotechnology	INN Generics	Biosimilars	Animal Health	Royalty Company
2003	77%	14%	1%	1%	5%	2%	-	0%	0%
2021	48%	20%	13%	4%	7%	4%	1%	2%	1%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2021

More information

Region

Worldwide

Survey time period

2003 and 2021

Supplementary notes

* Value means value of the commercial side of the drug sector. Torreya estimates it at approximately $7.03 trillion. Of this, $6.1 trillion is associated with publicly-traded companies.
In this statistic “Big pharma” is classified as the 18 largest companies in the sector by value. The biotech sector seems smaller than some might have expected. This is because we classify a company with no approved product as a “biotechnology company” and a company with a marketed product that is not a big pharma, not a Japan pharma nor a China branded generic pharma as a branded pharma company. Thus, many companies (think Incyte or Biogen) that some would think of as biotech are classified by us as branded pharma.

Citation formats